Medel-Matus Jesús-Servando, Reynolds Ashley, Shin Don, Sankar Raman, Mazarati Andrey
Department of Pediatrics, David Geffen School of Medicine at UCLA, Los Angeles, California, U.S.A.
Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, California, U.S.A.
Epilepsia. 2017 Aug;58(8):e122-e126. doi: 10.1111/epi.13826. Epub 2017 Jun 20.
This study examined whether Toll-like receptors 2 (TLR2) contribute to rapid kindling epileptogenesis. A TLR2 agonist, lipoteichoic acid (LTA), LTA antibody (LTA-A), or normal saline (control) was administered daily over 3 consecutive days, unilaterally into ventral hippocampus of adult male Wistar rats. Thirty minutes after the last injection, the animals were subjected to a rapid kindling procedure. The ictogenesis was gauged by comparing afterdischarge threshold (ADT) and afterdischarge duration (ADD) before the treatments, after the treatments prior to kindling, and 24 h after kindling. Kindling progression and retention were analyzed using video recording. The results showed that before kindling, LTA produced an ADT reduction. Neither LTA nor LTA-A affected baseline ADD. On kindling progression, LTA accelerated occurrence of generalized seizures, whereas LTA-A delayed this effect. Treatment with LTA-A reduced the number of secondary generalized complex partial seizures. Twenty-four hours after kindling, the rats of both the saline and LTA groups showed increased hippocampal excitability as compared with prekindling parameters. Administration of LTA-A prevented kindling-induced increase of hippocampal excitability. Immunostaining revealed that LTA-A attenuated the inflammatory response produced by seizures. These findings suggest that the activation of TLR2 in the hippocampus may facilitate limbic epileptogenesis.
本研究检测了Toll样受体2(TLR2)是否有助于快速点燃癫痫发作的发生。将TLR2激动剂脂磷壁酸(LTA)、LTA抗体(LTA-A)或生理盐水(对照)连续3天每天单侧注射到成年雄性Wistar大鼠的腹侧海马体中。最后一次注射后30分钟,对动物进行快速点燃程序。通过比较治疗前、点燃前治疗后以及点燃后24小时的放电阈值(ADT)和放电持续时间(ADD)来评估癫痫发作的发生。使用视频记录分析点燃进程和维持情况。结果显示,在点燃前,LTA使ADT降低。LTA和LTA-A均未影响基线ADD。在点燃进程方面,LTA加速了全身性癫痫发作的出现,而LTA-A则延迟了这种作用。LTA-A治疗减少了继发性全身性复杂部分性癫痫发作的次数。点燃后24小时,生理盐水组和LTA组的大鼠与点燃前参数相比,海马体兴奋性均增加。LTA-A给药可防止点燃诱导的海马体兴奋性增加。免疫染色显示,LTA-A减弱了癫痫发作产生的炎症反应。这些发现表明,海马体中TLR2的激活可能促进边缘系统癫痫发作的发生。